• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环可溶性白细胞介素-6受体而非ADAM17激活驱动组织炎症中的单核细胞迁移。

Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.

作者信息

Schumacher Neele, Schmidt Stefanie, Schwarz Jeanette, Dohr Dana, Lokau Juliane, Scheller Jürgen, Garbers Christoph, Chalaris Athena, Rose-John Stefan, Rabe Björn

机构信息

Institute of Biochemistry, Medical Faculty, Christian Albrechts University, 24098 Kiel, Germany; and.

Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.

出版信息

J Immunol. 2016 Nov 1;197(9):3705-3715. doi: 10.4049/jimmunol.1600909. Epub 2016 Oct 3.

DOI:10.4049/jimmunol.1600909
PMID:27698010
Abstract

Neutrophil and mononuclear cell infiltration during inflammatory processes is highly regulated. The first cells at the site of infection or inflammation are neutrophils, followed by mononuclear cells. IL-6 plays an important role during inflammatory states. It has been shown in several models that the soluble form of IL-6R (sIL-6R) is involved in the recruitment of mononuclear cells by a mechanism called IL-6 trans-signaling. It had been speculated that sIL-6R was generated at the site of inflammation by shedding from neutrophils via activation of the metalloprotease ADAM17. Attempts to genetically delete the floxed ADAM17 gene selectively in myeloid cells infiltrating an air pouch cavity upon injection of carrageenan failed because in transgenic mice, LysM did not lead to appreciable loss of the ADAM17 protein in these cells. We therefore used ADAM17 hypomorphic mice, which only express ∼5% of ADAM17 wild-type levels in all tissues and show virtually no shedding of all tested ADAM17 substrates, to clarify the role of ADAM17 during local inflammation in the murine air pouch model. In the present study, we demonstrate that although IL-6 and the trans-signaling mechanism is mandatory for cellular infiltration in this model, it is not ADAM17-mediated shedding of IL-6R within the pouch that orchestrates this inflammatory process. Instead, we demonstrate that sIL-6R is infiltrating from the circulation in an ADAM17-independent process. Our data suggest that this infiltrating sIL-6R, which is needed for IL-6 trans-signaling, is involved in the controlled resolution of an acute inflammatory episode.

摘要

炎症过程中中性粒细胞和单核细胞的浸润受到高度调控。感染或炎症部位最早出现的细胞是中性粒细胞,随后是单核细胞。白细胞介素-6(IL-6)在炎症状态中发挥重要作用。在多个模型中已表明,IL-6受体的可溶性形式(sIL-6R)通过一种称为IL-6转信号传导的机制参与单核细胞的募集。据推测,sIL-6R是在炎症部位通过金属蛋白酶ADAM17激活后从中性粒细胞上脱落而产生的。在注射角叉菜胶后,试图在浸润气袋腔的髓样细胞中选择性地基因敲除floxed ADAM17基因,但未成功,因为在转基因小鼠中,LysM并未导致这些细胞中ADAM17蛋白明显缺失。因此,我们使用ADAM17低表达小鼠,其在所有组织中仅表达约5%的ADAM17野生型水平,并且几乎没有所有测试的ADAM17底物的脱落,以阐明ADAM17在小鼠气袋模型局部炎症中的作用。在本研究中,我们证明,尽管IL-6和转信号传导机制在该模型中对细胞浸润是必需的,但并非气袋内ADAM17介导的IL-6R脱落协调了这一炎症过程。相反,我们证明sIL-6R是以一种不依赖ADAM17的过程从循环中浸润进来的。我们的数据表明,这种参与IL-6转信号传导所需的浸润性sIL-6R,参与了急性炎症发作的可控消退。

相似文献

1
Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.循环可溶性白细胞介素-6受体而非ADAM17激活驱动组织炎症中的单核细胞迁移。
J Immunol. 2016 Nov 1;197(9):3705-3715. doi: 10.4049/jimmunol.1600909. Epub 2016 Oct 3.
2
Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.切割位点定位对ADAM10和ADAM17介导的白细胞介素-6受体蛋白水解的调控存在差异
Sci Rep. 2016 May 6;6:25550. doi: 10.1038/srep25550.
3
Enhancing Interleukin-6 and Interleukin-11 receptor cleavage.增强白细胞介素-6 和白细胞介素-11 受体的裂解。
Int J Biochem Cell Biol. 2017 Apr;85:6-14. doi: 10.1016/j.biocel.2017.01.014. Epub 2017 Jan 29.
4
The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.白细胞介素-6受体Asp358Ala单核苷酸多态性rs2228145使ADAM蛋白酶的蛋白水解转化率增加。
Biochim Biophys Acta. 2014 Sep;1842(9):1485-94. doi: 10.1016/j.bbadis.2014.05.018. Epub 2014 May 27.
5
ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses.ADAM17通过在炎症反应期间从白细胞细胞表面切割小鼠IL-6Rα来控制IL-6信号传导。
J Leukoc Biol. 2016 May;99(5):749-60. doi: 10.1189/jlb.3A0515-207R. Epub 2015 Nov 11.
6
Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.白细胞介素 6(IL-6)转信号中 ADAM10 和 ADAM17 蛋白的物种特异性和 ADAM10 在诱导型 IL-6 受体脱落中的新作用。
J Biol Chem. 2011 Apr 29;286(17):14804-11. doi: 10.1074/jbc.M111.229393. Epub 2011 Mar 15.
7
Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.白细胞介素-6及其可溶性受体亚型对中性粒细胞激活趋化因子的差异调节
J Immunol. 2004 May 1;172(9):5676-83. doi: 10.4049/jimmunol.172.9.5676.
8
Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.内源性白细胞介素-6受体(IL-6R)的脱落由一种去整合素和金属蛋白酶(ADAM)蛋白酶调控,而全长IL-6R异构体定位于循环微泡。
J Biol Chem. 2015 Oct 23;290(43):26059-71. doi: 10.1074/jbc.M115.649509. Epub 2015 Sep 10.
9
Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.最小化白细胞介素 6(IL-6)受体茎组成用于 IL-6 受体脱落和 IL-6 经典信号传导。
J Biol Chem. 2013 May 24;288(21):14756-68. doi: 10.1074/jbc.M113.466169. Epub 2013 Apr 5.
10
Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling.金属蛋白酶 Meprin 生成具有生物活性的可溶性白细胞介素-6 受体,诱导转信号。
Sci Rep. 2017 Mar 9;7:44053. doi: 10.1038/srep44053.

引用本文的文献

1
iRhom2 deficiency reduces sepsis-induced mortality associated with the attenuation of lung macrophages in mice.iRhom2 缺乏可降低脓毒症诱导的小鼠死亡率,与肺巨噬细胞的衰减有关。
Histochem Cell Biol. 2024 Nov;162(5):415-428. doi: 10.1007/s00418-024-02318-5. Epub 2024 Aug 12.
2
Immune analysis of urine and plasma samples from patients with clear cell renal cell carcinoma.对透明细胞肾细胞癌患者的尿液和血浆样本进行免疫分析。
Oncol Lett. 2024 Apr 25;27(6):281. doi: 10.3892/ol.2024.14414. eCollection 2024 Jun.
3
A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma.
基于免疫原性细胞死亡相关基因的模型可预测肾透明细胞癌的预后及对免疫治疗的反应。
Transl Cancer Res. 2024 Jan 31;13(1):249-267. doi: 10.21037/tcr-23-214. Epub 2024 Jan 29.
4
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma.高血清白细胞介素-6水平预示着帕博利珠单抗联合阿昔替尼治疗晚期肾细胞癌患者的疗效不佳。
Cancers (Basel). 2022 Dec 3;14(23):5985. doi: 10.3390/cancers14235985.
5
The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand release.iRhom 同源结构域对于 ADAM17 介导的 TNFα 和 EGF 受体配体的释放是不可或缺的。
Cell Mol Life Sci. 2021 Jun;78(11):5015-5040. doi: 10.1007/s00018-021-03845-3. Epub 2021 May 5.
6
The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells.白细胞介素-6 的持续存在受来源于树突状细胞的血液缓冲系统调节。
Immunity. 2021 Feb 9;54(2):235-246.e5. doi: 10.1016/j.immuni.2020.12.001. Epub 2020 Dec 22.
7
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers.血清 IL6 作为胆道癌的预后生物标志物和 IL6R 作为治疗靶点。
Clin Cancer Res. 2020 Nov 1;26(21):5655-5667. doi: 10.1158/1078-0432.CCR-19-2700. Epub 2020 Sep 15.
8
Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis.单克隆抗体阻断 ADAM17 功能可改善多微生物脓毒症小鼠模型的脓毒症存活率。
Int J Mol Sci. 2020 Sep 12;21(18):6688. doi: 10.3390/ijms21186688.
9
A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases.联合治疗方法可恢复细胞因子平衡并抑制病毒生长,从而促进重症 COVID-19 患者康复。
Cytokine. 2020 Dec;136:155228. doi: 10.1016/j.cyto.2020.155228. Epub 2020 Aug 15.
10
Joint Reconstituted Signaling of the IL-6 Receptor via Extracellular Vesicles.白细胞介素 6 受体通过细胞外囊泡的联合重建信号传导。
Cells. 2020 May 24;9(5):1307. doi: 10.3390/cells9051307.